Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study

Children with Down syndrome (DS) are at significant risk for respiratory syncytial virus (RSV) infection and related hospitalization. We compared hospitalization rates due to respiratory tract infection in children with DS aged

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2014-06, Vol.133 (6), p.1031-1037
Hauptverfasser:	Yi, Hao, Lanctôt, Krista L, Bont, Louis, Bloemers, Beatrijs L P, Weijerman, Michel, Broers, Chantal, Li, Abby, Kiss, Alexander, Mitchell, Ian, Paes, Bosco
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Birth Weight Canada Care and treatment Child Cohort Studies Complications and side effects Cross-Sectional Studies Dosage and administration Down syndrome Down Syndrome - complications Down Syndrome - epidemiology Drug use Female Gestational Age Hospital care Hospitalization Hospitalization - statistics & numerical data Humans Incidence Infant Infant, Newborn Infant, Premature, Diseases - epidemiology Infant, Premature, Diseases - prevention & control Male Netherlands Nosocomial infections Palivizumab Pediatrics Prophylaxis Prospective Studies Registries Respiratory syncytial virus Respiratory syncytial virus infection Respiratory Syncytial Virus Infections - epidemiology Respiratory Syncytial Virus Infections - prevention & control Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Children with Down syndrome (DS) are at significant risk for respiratory syncytial virus (RSV) infection and related hospitalization. We compared hospitalization rates due to respiratory tract infection in children with DS aged
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.2013-3916